Personalized Treatment for Refractory H Pylori Infection

NACompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

August 1, 2012

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

rabeprazole+3 antibiotics

(rabeprazole 20 mg q.d.s. and three effective antibiotics) for 14 days.

DRUG

rabeprazole+bismuth+2 antibiotics

(rabeprazole 20 mg q.d.s., bismuth subcitrate 120 mg q.d.s. and all the effective antibiotics) for 14 days.

DRUG

rabeprazole+amox+tetr+levo

(rabeprazole 20 mg q.d.s, amoxicillin 500 mg q.d.s., tetracycline 500 mg q.d.s. and levofloxacin 500 mg o.d.) for 14 days.

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02547025 - Personalized Treatment for Refractory H Pylori Infection | Biotech Hunter | Biotech Hunter